Geneva, June 22 -- International Clinical Trials Registry received information related to the study (KCT0012115) titled 'Effect of Opiranserin as an Adjunct for Pain Control After Open Gastrectomy' on June 12.
Study Type: Interventional Study
Study Design:
Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Yonsei University Health System, Gangnam Severance Hospital
Condition:
Neoplasms
Intervention:
Drug : [Intervention group]
Opiranserin (Unafra(R)) 1000mg is diluted in normal saline to a total volume of 500ml and administered intravenously. Following completion of anesthesia induction, a loading dose of 160mg (80ml) i...